EITR BIOLOGICS, INC.: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2020 (FY2021), from USAspending.gov. UEI: HX49LZLY32G5
10contracts won
$39,606,181total obligated
$739,860median contract
Jul 01, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 1 | $33,059,642 |
| Department of Defense | 9 | $6,546,538 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
HT942626FE055 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Diego, CA |
— | Department of Defense Defense Health Agency |
$100,000 | Jul 01, 2026 Ends: Jun 30, 2027 |
| NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
HT942626FE033 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Diego, CA |
— | Department of Defense Defense Health Agency |
$269,999 | Apr 01, 2026 Ends: Mar 31, 2027 |
| NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
HT942526FE010 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Diego, CA |
— | Department of Defense Defense Health Agency |
$926,999 | Feb 01, 2026 Ends: Dec 31, 2027 |
| NOVEL NANOTHERAPEUTICS
HT942525F0221 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Diego, CA |
— | Department of Defense Defense Health Agency |
$300,000 | Jul 01, 2025 Ends: Jun 30, 2026 |
| NOVEL NANOTHERAPEUTICS
HT942524F0269 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Diego, CA |
— | Department of Defense Defense Health Agency |
$1,864,156 Potential value: $1,864,756 |
Sep 20, 2024 Ends: Dec 31, 2025 |
| DEVELOP A NOVEL ODIN THERAPEUTIC MEDICAL COUNTERMEASURE CAPABLE OF PROTECTING AGAINST PNEUMONIC UNENCAPSULATED Y. PESTIS.
HT942524F0127 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Diego, CA |
— | Department of Defense Defense Health Agency |
$499,896 | Jul 01, 2024 Ends: Jun 30, 2025 |
| SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN …
HT942524P0015 · NAICS 541380 Testing Laboratories and Services · San Diego, CA |
— | Department of Defense Defense Health Agency |
$729,721 Potential value: $1,303,427 |
Dec 06, 2023 Ends: Dec 10, 2025 |
| THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK …
75A50123C00060 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Diego, CA |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$33,059,642 Potential value: $317,552,135 |
Sep 22, 2023 Ends: Sep 30, 2027 |
| NOVEL NANOTHERAPEUTIC APPROACHES PENETRATING THE OUTER LAYERS OF THE BACTERIUM AND TARGETING OUTER MEMBRANE PROTEINS FOR THE TREATMENT OF PN…
HT942523F0306 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Diego, CA |
— | Department of Defense Defense Health Agency |
$750,000 | Sep 01, 2023 Ends: Aug 31, 2024 |
| NOVEL CELL SORTING
HT942523P0004 · NAICS 541380 Testing Laboratories and Services · Frederick, MD |
— | Department of Defense Defense Health Agency |
$1,105,767 Potential value: $1,665,254 |
Nov 28, 2022 Ends: Nov 27, 2024 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.